- Report
- December 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Clinical Trials
- November 2024
- 180 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- September 2024
- 184 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Clinical Trials
- January 2025
- 2461 Pages
Global
From €3280EUR$3,450USD£2,755GBP
- Report
- March 2025
- 287 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- May 2024
- 134 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Clinical Trials
- June 2024
- 80 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- May 2024
- 160 Pages
Global
From €4724EUR$4,969USD£3,968GBP
- Report
- April 2023
- 224 Pages
Global
From €7130EUR$7,500USD£5,990GBP
- Report
- April 2023
- 112 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- August 2022
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2022
- 120 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- November 2022
- 565 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- July 2018
- 50 Pages
Global
From €3798EUR$3,995USD£3,191GBP
- Report
- August 2022
Global
From €1036EUR$1,090USD£871GBP
- Drug Pipelines
- October 2020
- 773 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- March 2024
- 117 Pages
Global
From €3500EUR$3,944USD£3,043GBP

The Stroke Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat and prevent cardiovascular diseases. Stroke drugs are used to treat ischemic and hemorrhagic strokes, which are caused by a disruption of blood flow to the brain. These drugs can help reduce the risk of stroke recurrence and improve patient outcomes. Common stroke drugs include anticoagulants, antiplatelet agents, thrombolytics, and antithrombotics. Anticoagulants are used to prevent blood clots from forming, while antiplatelet agents are used to prevent existing clots from getting bigger. Thrombolytics are used to dissolve existing clots, while antithrombotics are used to prevent clot formation.
Some companies in the Stroke Drug market include Pfizer, Merck, Sanofi, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more